Who is sponsoring NCT04983056?

NCT04983056 is sponsored by Sylvestre KABURA.

What drugs are being tested in NCT04983056?

Interventions in NCT04983056: Necrotesectomy associated with cleanleness stoma.

What condition does NCT04983056 study?

NCT04983056 studies Fournier Gangrene.

Is NCT04983056 still recruiting?

NCT04983056 is currently completed. Last updated 30 July 2021.

Last reviewed 2021-07-30 · How we verify

NCT04983056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Management of Fournier Gangrene at Ibn Rochd University Hospital Center

Completed Last updated 30 July 2021

What this trial tests

trial testing Necrotesectomy associated with cleanleness stoma in Fournier Gangrene in 84 participants. Completed in 2 July 2021.

Timeline

1 January 2010

Primary endpoint
31 March 2017

2 July 2021

Quick facts

Lead sponsor	Sylvestre KABURA
Status	Completed
Study type	OBSERVATIONAL
Enrollment	84
Start date	1 January 2010
Primary completion	31 March 2017
Estimated completion	2 July 2021

Drugs / interventions tested

Necrotesectomy associated with cleanleness stoma

Conditions studied

Fournier Gangrene — all drugs for Fournier Gangrene →

Sponsor

Sylvestre KABURA

Who can join

Adults 15 to 100, any sex, with Fournier Gangrene. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Case series with retrospective data collection of patients treated for Fournier's gangrene between January 2010 and March 2017. The main etiologies, risk factors, postoperative complications outcomes and long term follow up results were analyzed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fournier's gangrene: Seven years of experience in the emergencies service of visceral surgery at Ibn Rochd University Hospital Center.
Bensardi FZ, Hajri A, Kabura S, Bouali M, et al · · 2021 · cited 7× · PMID 34777789 · DOI 10.1016/j.amsu.2021.102821

Verify or expand the search:

Other recruiting trials for Fournier Gangrene

Currently open trials in the same condition.

NCT07359651 — FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI). · recruiting

Other Sylvestre KABURA trials

Trials by the same sponsor.

NCT05186402 — Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series · completed
NCT05068635 — Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04983056 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sylvestre KABURA
Last refreshed: 30 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing